Adjuvant Treatment for Gastric Leiomyosarcoma

Introduction to Gastric Leiomyosarcoma Treatment

• For high-risk gastric leiomyosarcoma, doxorubicin-based chemotherapy is the recommended adjuvant treatment following complete surgical resection, with high-risk defined as tumors that are high-grade, deep, or >5 cm 1

Surgical Management

• Complete surgical resection with negative margins is the primary treatment for localized gastric leiomyosarcoma 2

Risk Assessment for Adjuvant Therapy

• Decision for adjuvant therapy should be based on risk factors including tumor grade, tumor size, depth of invasion, and margin status, with high-grade tumors, those larger than 5 cm, and those with deeper invasion considered high-risk 1

Adjuvant Chemotherapy Options

• Doxorubicin-based regimens are the standard first-line treatment for high-risk patients, with options including single-agent doxorubicin, doxorubicin plus dacarbazine, and doxorubicin plus ifosfamide for patients with good performance status 1

Radiation Therapy

• Postoperative radiation therapy has limited value in leiomyosarcoma and is associated with significant toxicities 3
• Radiation therapy did not improve survival or relapse-free survival in a randomized trial of leiomyosarcoma 4

Second-line Treatment Options

• Trabectedin has proven effective in leiomyosarcoma after failure of anthracycline-based therapy 1
• Gemcitabine with or without docetaxel has shown activity in leiomyosarcoma 1
• Dacarbazine has demonstrated activity as second-line therapy, and gemcitabine plus dacarbazine has shown improved overall survival and progression-free survival over dacarbazine alone 1

Special Considerations

• Approximately 50% of leiomyosarcomas may express estrogen and/or progesterone receptors, and hormone replacement therapy containing estrogens is contraindicated in patients with leiomyosarcoma 5

Follow-up Recommendations

• High-grade patients should be followed every 3-4 months in the first 2-3 years, then twice a year up to the fifth year, and once a year thereafter, with follow-up including appropriate imaging to detect recurrence 2
• MRI is preferred for local recurrence detection, while CT is used for lung metastases surveillance 6

Treatment Decisions

• Treatment decisions should be made in centers with expertise in sarcoma management 1